Financial Performance - The company's revenue for Q1 2022 was ¥89,780,416.22, a decrease of 1.11% compared to ¥90,788,361.33 in the same period last year[3] - Net profit attributable to shareholders decreased by 50.04% to ¥5,631,558.31 from ¥11,271,909.40 year-on-year[3] - The company reported a profit before tax of ¥666.69 million, a decline of 49.16% from ¥1,311.40 million year-on-year[9] - The company reported a net profit of CNY 6,029,069.05 for the quarter, compared to CNY 12,382,824.95 in the same quarter last year, indicating a decrease of 51.32%[19] - The net profit for Q1 2022 was CNY 5,642,865.85, a decrease of 50.4% compared to CNY 11,383,850.98 in the same period last year[20] - The operating profit for Q1 2022 was CNY 6,637,914.84, down 49.1% from CNY 13,068,643.57 in Q1 2021[20] - The total comprehensive income for Q1 2022 was CNY 5,642,865.85, compared to CNY 11,383,850.98 in Q1 2021, reflecting a decline of 50.4%[21] - The basic and diluted earnings per share for Q1 2022 were both CNY 0.04, down from CNY 0.09 in the previous year[21] Cash Flow - The net cash flow from operating activities improved by 80.56%, reaching -¥3,319,531.33 compared to -¥17,074,959.26 in the previous year[3] - The net cash flow from operating activities for Q1 2022 was negative CNY 3,319,531.33, an improvement from negative CNY 17,074,959.26 in Q1 2021[23] - Cash inflow from investment activities in Q1 2022 was CNY 20,171,027.40, significantly lower than CNY 65,638,836.90 in the same period last year[23] - The net cash flow from financing activities for Q1 2022 was negative CNY 18,104,521.95, compared to positive CNY 12,722,203.84 in Q1 2021[23] Assets and Liabilities - Total assets decreased by 3.15% to ¥741,178,086.59 from ¥765,252,316.13 at the end of the previous year[3] - Total liabilities decreased to CNY 185,298,606.89 from CNY 215,154,679.45, a decline of 13.88%[17] - The company's equity attributable to shareholders increased to CNY 552,034,421.75 from CNY 546,284,181.73, an increase of 1.30%[18] Research and Development - Research and development expenses increased by 39.13% to ¥525.09 million, reflecting the company's commitment to enhancing R&D investment[8] - Research and development expenses rose to CNY 5,250,946.81, reflecting a 39.06% increase from CNY 3,774,159.76 in the previous year[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,576[12] Financial Expenses - The company experienced a significant reduction in financial expenses by 90.19%, amounting to ¥9.63 million compared to ¥98.20 million in the previous year[9] Inventory and Receivables - Accounts receivable decreased to CNY 157,547,608.86 from CNY 161,632,760.41, a decline of 2.54%[16] - Inventory decreased to CNY 87,709,290.79, down 4.30% from CNY 91,655,735.14 at the beginning of the year[16] Cash and Cash Equivalents - Cash and cash equivalents at the end of the period were CNY 66,706,421.19, down 27.56% from CNY 92,154,221.36 at the beginning of the year[15] - The total cash and cash equivalents at the end of Q1 2022 were CNY 66,706,421.19, down from CNY 70,892,482.76 at the beginning of the period[23] - The company reported a foreign exchange impact of CNY 22,034.25 on cash and cash equivalents during Q1 2022[23] Audit Information - The company has not undergone an audit for the Q1 2022 report[25]
优德精密(300549) - 2022 Q1 - 季度财报